PART VI BIBLIOGRAPHY

"History is the only laboratory we have in which to test the consequences of thoughts".

– Anonymous –

 

 

211

VI: BIBLIOGRAPHY

9. References

Abramson LY, Seligman MEP (1978). Modeling psychopathology in the laboratory: History and rationale. In: Psychopathology: Experimental models, Maser JD, Seligman MEP (eds.), San Francisco, Freeman. p. 1–26.

Acosta-Madrid II, Castaneda-Hernandez G, Cilia-Lopez VG, Carino-Cortes R, Perez-

Hernandez N, Fernandez-Martinez E, et al (2009). Interaction between Heliopsis longipes extract and diclofenac on the thermal hyperalgesia test. Int J phytother phytopharmacol; 16: 336–41.

Agmo A, Belzung C, Giordano M (1996). Interactions between dopamine and GABA

in the control of ambulatory activity. J Neural Transm; 103: 925–34. Agrawal OP, Raju PS (2006). Global market of herbal products: Opportunities for

India. In: Traditional system of medicine Abdin MZ, Abroi YP (eds.), Narosa Publishing House: New Delhi, India. p. 5–10.

Aithal HN, Sirsi M (1961). Pharmacological investigation on Herpestis monniera. Ind J

Pharm; 23: 2–5. Almeida JC, Grimsley EW (1996). Coma from the health food store: interaction

between kava and alprazolam. Ann Intern Med; 125: 940–1. Aloe A, Alleve E, Fiore M (2002). Stress and nerve growth factor findings in animal

models and humans. Pharmacol Biochem Behav; 73:159–66. Ameer B, Weintraub RA (1997). Drug interactions with grapefruit juice. Clin

Pharmacokin; 33:103–21. Amin AH, Crawford TB, Gaddum JH (1954). The distribution of substance P and 5-

hydroxytryptamine in the central nervous system of the dog. J Physiol; 126: 596–618. Ammon HPT, Wahl MA (1991). Pharmacology of Curcuma longa. Planta Med; 57:1–

7. Anbarasi K, Vani G, Balakrishna K, Devi CS (2006). Effect of bacoside A on brain

antioxidant status in cigarette smoke exposed rats. Life Sci; 78:1378–84. Anderson AM, Mitchell MS, Mohan RS (2000). Isolation of curcumin from turmeric. J

Chem; 77: 3. Anonymous (2008). Possible interaction with turmeric.A.D.A.M. Inc. University of

Maryland Medical Center (UMMC). Available from http://www.umm.edu/altmed/articles/turmeric-000932.htm (Consulted, May 12, 2008).

Anonymous (2008). Centella asiatica Selected Triterpenes (CAST) for Diabetic

Neuropathy. National Center for Complementary and Alternative Medicine (NCCAM). United States: Food and Drug Administration 2008. Clinical trials.gov identifier: NCT00608439 available from: http://ompress.com/NCCT2005.pdf (Consulted, May 12, 2008).

212

Anonymous (1996). Clinical development plan: Curcumin. Chemoprevention Branch

and Agent Development Committee. J Cell Biochem; 26: S72–85. Anonymous (1994). Dietary Supplement Health and Education Act of 1994, Public

Law 103-417. Available at http://www.fda.gov/opacom/laws/dshea.html#sec3. (Consulted, August 28, 2006).

Appa Rao MVR, Srinivasan K, Rao KT (1973). The effect of Mandookaparni (Centella

asiatica) on the general mental ability (Medhya) of mentally retarded children. J Res Ind Med; 8: 9–16.

Appiah-Opong R, Commandeur JN, van Vugt-Lussenburg B, Vermeulen NP (2007).

Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicol; 235: 83–91.

Archer J (1973). Test for emotionality in rats and mice: a review. Anim Behav; 21:

205–35. Armstrong SC, Cozza KL, Cole MA (2000). Consultation-liaison psychiatry drug-drug

interactions update. Psychosomatics; 41: 375–6. Arunrut T, Alejandre H, Chen M, Joseph Cha J, Russo-Neustadt A (2009). Differential

behavioral and neurochemical effects of exercise, reboxetine and citalopram with the forced swim test. Life Sci; 84: 584–9.

Arnsten AFT (1997). Catecholamine regulation of the prefrontal cortex. J

Psychopharmacol; 11: 151–62. Aslam M, Stockley IH (1979). Interaction between curry ingredient (karela) and drug

(chlorpropamide). Lancet; 1: 607. Babu PS, Shrinivasan K (1997). Hypolipidemic action of curcumin, the active principle

of turmeric (Curcuma longa) in streptezotecin induced diabetic rats. Mol Cell Biochem; 166: 169–75.

Bafna PA, Balaraman R (2005). Antioxidant activity of DHC-1, an herbal formulation,

in experimentally-induced cardiac and renal damage. Phytother Res; 19: 216–21. Bailey DG, Spence JD, Edgar B, Bayliff CD, Arnold JMO (1989). Ethanol enhances

the hemodynamic effects of felodipine. Clin Invest Med; 12: 357–62. Bailey DG, Spence JD, Munoz C, Arnold JM (1991). Interaction of citrus juice with

felodipine and nifedipine, Lancet; 337: 268–9. Baily E (1945). Treatment of leprosy. Nature; 155: 601. Bakhru, HK (1997). Herbs that heal: natural remedies for good health. Orient

Paperbacks, New Delhi. p. 164–6. Baldessarini RJ (2001). Drugs and treatment of psychiatric disorders. Depression and

mania. In: Goodman & Gilman’s the Pharmacological basis of therapeutics, Hardman JG, Limbard LE, Molinoff PB, (eds.), 10th edition, New York: McGraw-Hill.p. 447-83.

213

Barbenel DM, Yusufi B, O’Shea D, Bench CJ (2000). Mania in a patient receiving

testosterone replacement postorchidectomy taking St. John’s wort and sertraline. J Psychopharmacol; 14: 84–6.

Barnes P, Powell-Griner E, McFann K, Nahin R (2004). CDC Advance data reports

No. 343. Complementary and alternative medicine use among adults: United States, 2002. U. S Department of Health and Human Services (Center for disease control and prevention, National Center for Health Statistics). p. 1-20. DHHS Publication No. (PHS) 2004-1250. Avalible from: http://www.medicalacupuncture.org/events/cam_survey.html (Consulted, June 19, 2006)

Barrett SCH, Strother JL (1978). Taxonomy and natural history of bacopa in California.

Syst Bot; 5: 408–19. Baum L, Cheung SK, Mok VC, Lam LC, Leung VP, Hui E, et al (2007). Curcumin

effects on blood lipid profile in a 6-month human study. Pharmacol Res; 56: 509–14. Baumans V (2005). Environmental enrichment for laboratory rodents and rabbits:

requirements of rodents, rabbits and research. ILAR J; 46: 162–70. Beckmann-Knopp S, Rietbrock S, Weyhenmeyer R, Bocker RH, Beckurts KT, Lang,

W (2000). Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes. Pharmacol Toxicol; 86: 250–6.

Berton O, Nestler EJ (2006). New approaches to antidepressant drug discovery: beyond

monoamines. Neurosci; 7: 137–51. Bhakuni DS, Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN (1969). Screening of

Indian plants for biological activity: Part II. Ind J Exp Biol; 7: 250–62. Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S (2000). Antioxidant activity of

Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother Res; 14: 174–9.

Bhattacharya SK, Ghosal S (1998). Anxiolytic activity of a standardized extracts of

Bacopa monniera: an experimental study. Phytomed; 5: 77–82. Bhattacharya SK, Kumar A, Ghosal S (1999a). Effect of Bacopa monniera on animal

models of Alzheimer’s disease and perturbed central cholinergic markers of cognition in rats. In: Molecular Aspects of Asian Medicines, Siva Sankar DV (ed.), New York: PJD Publications. p. 27–58.

Bhattacharya SK, Satyan KS, Ramanathan M (1999b). Experimental methods for

evaluation off psychotropic agents in rodents: II- Antidepressants. Ind J Exp Biol; 37: 117–23.

Bhattacharya, SK (1993). In Manual, Pre-conference workshop on research

methodology. Annual Conference of Indian Pharmacological Society. Binder EB, Kinkead B, Owens MJ, Nemeroff CB (2001). Neurotensin and dopamine

interactions. Pharmacol Rev; 53: 453–86. Bindra, D, Thompson, WR (1953). An evaluation of defecation and urination as

measures of fearfulness. J Comp Physiol Psychol; 46: 43–5.

214

Bissette G (2001). Effects of sertraline on regional neuropeptide concentrations in

olfactory bulbectomized rats. Pharmacol Biochem Behav; 69: 269–81. Blier P, Abbott FV (2001). Putative mechanisms of actions of antidepressant drugs in

affective and anxiety disorders in pain. J Psychiatry Neurosci; 26: 37–43. Blier P, de Montigny C (1998). Possible serotonergic mechanisms underlying the

antidepressant and anti-obsessive–compulsive disorder responses. Biol Psychiatry; 44: 313–23.

Blier P, Ward NM (2003). "Is there a role for 5-HT1A agonists in the treatment of

depression?” Biol Psychiatr; 53: 193–203. Blumenthal M (2000). Interactions between herbs and conventional drugs: introductory

considerations. Herbalgram; 49:52–63. Bogdansky DF, Pletscher A, Brodie BB, Udenfriend S (1956). Identification and assay

of serotonin in brain. J Pharmacol Exp Ther; 117: 82–8. Bolles RC, Woods PJ (1964). The ontogeny of behaviour in the albino rat. Anim

Behav; 12: 427–41 Booth SL, Centurelli MA, Mayer J. Vitamin K (1999). A practical guide to dietary

management of patients on warfarin. Nutr Rev; 57: 288–96. Borsini F, Meli A (1988). Is the forced swimming test a suitable model for revealing

antidepressant activity? Psychopharmacol; 94: 147–60. Borsini F, Bendotti C, Velkov V, Rech R, Samanm R (1981). Immobility test: effects of

5-hydroxytryptaminergic drugs and role of catecholamines in the activity of some antidepressants. J Pharm Pharmacol; 33: 33–7.

Borsini F, Mancinelli A, D’ Aranno Y, Evangelista S, Meli A (1986). Role of GABA in

the forced swimming test (FST) in rats. Psychopharmacol; 89: S9. Bose KC, Bose, NK (1931). Observations on the actions and uses of Herpestis

monniera. J Ind Med Assoc; 1: 60. Boullata J (2005). Natural health product interactions with medication. Nutr Clin Pract;

20:33–51. Bowman RL, Caulfield PA, Udenfriend S (1955). Spectrophotofluorimetric assay in the

visible and ultraviolet. Sci; 122: 32–3. Bown D (1995). Encyclopaedia of herbs and their uses. Dorling Kindersley, London. Brazier NC, Levine MA (2003). Drug-herb interaction among commonly used

conventional medicines: A compendium for health care professionals. Am J Ther; 10: 163–69.

Bresssler R (2005). St. John’s wort and prescription medications. Geriatr; 60: 21–3. Brinker F (2008). Updates and additions for herb contradictions and drug interactions,

3rd edition 2008. Available from: http://www.eclecticherb.com/emp/updatesHCDI.html (Consulted, May 12, 2008).

215

Brinker F (1998). Herbal contraindications and drug interactions, 2nd edition, Sandy

(OR): Eclectic Medical Publications. Brinkhaus B, Lindner M, Schuppan D, Hahn EG (2000). Chemical, pharmacological

and clinical profile of the East Asian medical plant Centella asiatica. Phytomed; 7: 427–48.

Broadhurst PL, Eysenck HJ (1964). Interpretations of exploratory behaviour in the rat.

In: Experiments in motivation. Eysenck HJ (ed.), Oxford: Pergamon. Brouet I, Ohshima H (1995). Curcumin, an anti-tumour promoter and anti-

inflammatory agent, inhibits induction of nitric oxide synthetase in activated macrophages. Biochem Biophys Res Commun; 206: 533–40.

But PP-H (1994). Herbal poisoning caused by adulterants or erroneous substitutes. J

Trop Med Hyg; 97: 371–74. Butterweck V (2003). Mechanism of action of St. John’s wort in depression: what is

known? CNS Drugs; 17:539–62. Calabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B (2008). Effects of a

Standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: A randomized, double-blind, placebo-controlled trial. J Alt Comp Med; 14: 707–13.

Cassens GP, Actor C, Kling M, Schildkraut JJ (1981). Amphetamine withdrawal effects

threshold of intracranial self-stimulation. Psychopharmacol; 73: 318–22. Chakravarty AK, Garai S, Masuda K, Nakane T, Kawahara, N (2003). Bacopasides III–

V: three new triterpenoid glycosides from Bacopa monniera. Chem Pharm Bull; 51: 215–17.

Chakravarty AK, Sarkar T, Masuda K, Shiojima K, Nakane T, Kawahara N (2001).

Bacopa side I and II: two pseudojujubogenin glycosides from Bacopa monniera. Phytochem; 58: 553–6.

Chakravarty AK, Sarkar T, Nakane T, Kawahara N, Masuda K (2002). New

phenylethanoid glycosides from Bacopa monniera. Chem Pharm Bull; 50: 1616–18. Chandel, RS, Kulshreshtha, DK, Rastogi, RP (1977). Bacogenin A3: a new sapogenin

from Bacopa monniera. Phytochem; 16: 141–43. Chandler-Laney PC, Castaneda E, Pritchett CE, Smith ML, Giddings M, Artiga AI

(2007). A history of caloric restriction induces neurochemical and behavioral changes in rats consistent with models of depression. Pharmacol Biochem Behav; 87: 104–14.

Channa S, Dar A, Yaqoob M, Anjum S,Sultani Z, Rahman A (2003).

Bronchovasodilatory activity of fractions and pure constituents isolated from Bacopa monniera. J Ethnopharmacol; 86: 27–35.

Channa S, Dar, A, Anjum S, Yaqoob M, Rahman A (2006). Anti-inflammatory activity

of Bacopa monniera in rodents. J Ethnopharmacol; 104: 286–9. Charrois TL, Hill RL, Vu D, Foster BC, Boon HS, Cramer K, et al (2007). Community identification of natural health product–drug interactions. Ann Pharmacother; 41:1124–9.

216

Chatterji N, Rastogi RP, Dhar ML (1965). Chemical examination of Bacopa monniera

Wettst. Part II -isolation of chemical constituents. Ind J Chem; 3: 24–9. Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK (2004). Turmeric and

curcumin: biological actions and medicinal applications. Curr Sci; 87:44–53. Chavez ML, Jordan MA, Chavez PI (2006). Evidence based drug-herbal interactions.

Life Sci; 78: 2146–57. Cheema P, El-Mefty O, Jazieh AR (2001). Intraoperative haemorrhage associated with

the use of extract of saw palmetto herb: a case report and review of literature. J Int Med; 250: 167–69.

Cheeta S, Broekkamp C, Willner P (1994). Stereospecific reversal of stress-induced

anhedonia by mianserin and its (+)-enantiomer. Psychopharmacol; 116: 523–8. Chen YH, Han T, Qin L, Rui Y, Zheng H (2003). Effect of total triterpenes from

Centella asiatica on the depression behaviour and concentration of amino acid in forced swimming mice. Zhong Yao Cai; 26: 870–3.

Chen YH, Han T, Rui Y, Yin M, Qin L, Zheng H (2005). Effects of total triterpenes of

Centella asiatica on the corticosterone levels in serum and contents of monoamine in depression rat brain. Zhong Yao Cai; 28: 492–6.

Chen YH (1983). Studies on Chinese Curcuma. III. Comparison of the volatile oil and

phenolic constituents from the rhizome and the tuber of Curcuma longa. Zhong Yao Tong Bao; 8: 27–9.

Chevallier A (1996). The encyclopedia of medicinal plants, Dorling Kindersley.

London. Chopra RN (1958). Indigenous drugs of India, 2nd edition. U.N. Dhur and Sons,

Calcutta, India. p. 341. Chopra RN, Nayar L, Chopra IC (1956). Glossary of Indian medicinal plants; vol. 32.

Council of Scientific and Industrial Research, New Delhi. Chopra RN, Nayar SL, Chopra. IC (1986). Glossary of Indian medicinal plants

(Including the Supplement), Council of Scientific and Industrial Research, New Delhi. Chowdhuri DK, ParmarD, Kakkar P, Shukla R, Seth PK, Srimal RC (2002). Antistress

effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res; 16: 639–45.

Clineschmidt BV, Flatker LM, Faison E, Holms R (1979). An in vivo model for

investigating α1 and α2 receptors in the CNS: studies with mianserin. Arch Int Pharmacodyn Ther; 242: 59–76.

Cornelius R, Pawlak, CR, Ying-Jui Ho, Schwarting RKW (2008). Animal models of

human psychopathology based on individual differences in novelty-seeking and anxiety. Neurosci Biobehav Rev; 32: 1544–68.

Cott J, Engel J (1977). Suppression by GABAergic drugs of the locomotor stimulation

induced by morphine, amphetamine, and apomorphine: evidence for both pre- and post-synaptic inhibition catecholamine systems. J Neural Transm; 40: 253–68.

217

Crofton KM, Howard JC, Moser VC, Gill MW, Reiter LW. Tilson HA, et al (1991).

Interlaboratory comparisons of motor activity experiments: implications for neurotoxicological assessments. Neurotoxicol teratol; 13: 599–609.

Cryana JF, Markou A, Lucki I (2002). Assessing antidepressant activity in rodents:

recent developments and future needs. Trends Pharmacological Sci; 23: 238–45. Cryana, JF, Valentinob RJ, Luckia I (2005a). Assessing substrates underlying the

behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev; 29:547–69.

Cryana JF, Mombereau C, Vassout A (2005b). The tail suspension test as a model for

assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Psychiatr Neurosci Biobehav Rev; 29: 571–625.

Cryer PE (1984). Catecholamines and metabolism. Am J Phy endocrinol Metab; 10:

E1–3. Cupp MJ (1999). Herbal remedies: adverse effects and drug interactions. Am Fam Phy;

59:1239–45. Dahanukar SA, Kulkarni RA (2000). Pharmacology of medicinal plants and natural

products. Ind J Pharmacol; 32: S81–118. Dandekar UP, Chandra RS, Dalvi SS, Joshi MV, Gokhale PC, Sharma AV, et al (1992).

Analysis of a clinically important interaction between phenytoin and Shankhapushpi, an Ayurvedic preparation. J Ethnopharmacol; 35:285–8.

Dannawi M (2002). Possible serotonin syndrome after combination of buspirone and

St. John’s wort. J Psychopharmacol; 16: 401. Dar A, Channa S (1999). Calcium antagonistic activity of Bacopa monniera on

vascular and intestinal smooth muscles of rabbit and guinea-pig. J Ethnopharmacol; 66: 167–74.

Dar A, Channa S (1997). Relaxant effect of ethanol extract of Bacopa monniera on

trachea, pulmonary artery and aorta from rabbit and guinea-pig. Phytother Res; 11: 323–25.

De Montis MG, Gambarana C, Ghiglieri O, Tagliamonte A (1995). Reversal of stable

behavioural modifications through NMDA receptor inhibition in rats. Behav Pharmacol; 6: 562–7.

Deahl M (1989). Betel nut-induced extrapyramidal syndrome: an unusual drug

interaction. Mov Disord; 4: 330–2. Deepak M, Sangli GK, Arun PC, Amit A (2005). Quantitative determination of the major saponin mixture bacoside A in Bacopa monnieri by HPLC. Phytochem Anal; 16: 24–9. Deepak M (2003). The need for establishing identities of `bacoside A and B? The

putative major bioactive saponins of Indian medicinal plant. Phytomed; 11: 264–8. Dharmani P, Palit G (2006). Exploring Indian medicinal plants for antiulcer activity.

Ind J Pharmacol; 38: 95–9.

218

Di Carlo G, Borrelli F, Ernst E, Izzo AA (2001). St. John’s wort: Prozac from the plant

kingdom. Trends Pharmacol Sci; 22: 292–7. DiCenzo R, Shelton M, Jordan K, Koval, C, Forrest A, Reichman R, et al (2003). Co-

administration of milk thistle and indinavir in healthy subjects. Pharmacother; 23: 866–70.

Dikshit M, Rastogi L, Shukla R, Srimal RC (1995). Prevention of ischaemia-induced

biochemical changes by curcumin and quinidine in the cat heart. Ind J Med Res; 101: 31–5.

Dinh LD, Simmen U, Bueter KB, Bueter B, Lundstrom K, Schaffner W (2001).

Interaction of various Piper methysticum cultivars with CNS receptors in vitro. Planta Med; 67: 306–11.

Diwan PC, Karwande I, Singh AK (1991). Anti-anxiety profile of mandukparni

Centella asitica (Linn) in animals. Fitoterapia; 62:255–7. Donovan JL, Devane CL, Chavin KD, Tylor RM, Wang JS , Ruan Y, et al (2004).

Green tea (Camellia sinensis) extract does not alter cytochrome P-450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos; 32: 906–8.

Donovan JL, DeVane CL, Chavin KD, Taylor RM, Markowitz JS (2003). Siberian

ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. Drug Metab Dispos; 31: 519–22.

Dorababu M, Prabha,T, Priyambada S, Agrawal VK, Aryya NC, Goel RK (2004).

Effect of Bacopa monniera and Azadirachta indica on gastric ulceration and healing in experimental NIDDM rats. Ind J Exp Biol; 42: 389–97.

Dreier JP, Endres M (2004). Statin-associated rhabdomyolysis triggered by grapefruit

consumption. Neurol; 62: 670. Dresser GK, Schwarz UI, Wilkinson GR, Kim RB (2003). Coordinate induction of both

cytochrome P4503A and MDR1 by St. John’s wort in healthy subjects. Clin Pharmacol Ther; 73: 41–50.

Drevets WC (2000). Neuroimaging studies of mood disorders. Biol Psychiatr; 48:813–

29. Duke J (1985). Handbook of medicinal herbs. Boca Raton, FL: CRC Press. Duncun GE, Paul IA, Harden TK, Mueller RA, Stumpf WE, Breese GE (1985). Rapid

down regulation of beta-adrenergic receptors by combining antidepressant drugs with forced swim: A model of antidepressant-induced neural adaptation. J Pharmacol Exp Ther; 234: 402–08.

Dunham NM, Mija TS (1957). A note on a simple apparatus for detecting neurological

deficit in rats and mice. J Am Pharm Assoc; 46: 208–10. Durr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ, et al

(2000). St. John’s wort induces intestinal P- glycoprotein/ MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther; 68: 598–604.

Dutta T, Basu UP (1968). Crude extract of Centella asiatica and products derived from

its glycosides as oral antiferility agents. Ind J Exp Biol; 6:181.

219

Dziedzicka-Wasylewska M, Willner P, Papp M (1997). Changes in dopamine receptor

mRNA expression following chronic mild stress and chronic antidepressant treatment. Behav Pharmacol; 8: 607–18.

Edwards E, King JA, Fray J (2000). Hypertension and insulin resistant models have

divergent propensities to learned helpless behavior in rodents. Am J Hypertens; 13: 659–65.

Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al (1998).

Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA; 28: 1569–75.

Eisenberg M. David MD (1997). Advising patients who seek alternative medical

therapies. Annals Int Med; 127: 61–9. Elangovan V, Govindasamy S, Ramamoorthy N, Balasubramaanian K (1995). In vitro

studies on the anticancer activity of Bacopa monnieri. Fitoterapia; 66: 211–5. Engdal S, Klepp O, Nilsen OG (2009). Identification and exploration of herb-drug

combinations used by cancer patients. Integr Cancer Ther; 8: 29–36. Engler RJM, Catherine M, Gregory PJ, Jellin JM (2009). Complementary and

alternative medicine for the allergist-immunologist: where do I start? J Allergy Clin Immunol; 123: 317–8.

Erjavec MK, Coda BA, Nguyen Q, Donaldson G, Risler L, Shen DD (2000). Morphine-

fluoxetine interactions in healthy volunteers: Analgesia and side effects. J Clin Pharmacol; 40: 1286–95.

Ernst E, Pitter MH (2002). Herbal medicine. Med Clin North Am; 86: 149–61. Ernst E (2000a). Possible interactions between synthetic and herbal medicinal products.

Part 1: a systematic review of the indirect evidence. Perfusion; 13: 2200–11. Ernst E (2000b). Interactions between synthetic and herbal medicinal products. Part 2:

A systematic review of the direct evidence. Perfusion; 13: 60–70. Eun HC, Lee AY (1985). Contact dermatitis due to madecassol. Contact Dermatitis; 13:

310–3. Evans AM (2000). Influence of dietary components on the gastrointestinal metabolism

and transport of drugs. Ther Drug Monit; 22: 131–36. Eysenback G, Diepgen TL (1998). Towards quality management of medical

information on the internet: Evaluation, labeling and filtering of information. Br Med J; 317: 1496–1502.

Fan L, Tao G, Wang G, Chen Y, Zhang W, He Y, et al (2009). Effects of Ginkgo biloba

extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers. Ann pharmacother; 43: 944–9.

Feltrow CW, Avila JR (1999). Professsionals handbook of Complementary and

Alternative Medicines; Springhouse Corporations. Fessenden J, Wittenborn W, Clarke L (2001). Ginkgo biloba: A case report of herbal

medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am Surg; 67: 33–5.

220

Foster S (1996). Herbal medicine: An introduction for pharmacists. NARD J; 10:127–

44. Frazer A (1997). Pharmacology of antidepressants. J Clin Psychopharmacol; 17: 2S–

18S. Fugh-Berman A, Ernst E (2001). Herb-drug interactions: Review and assessment of

report reliability. Br J Clin Pharmacol; 52: 587–95. Fugh-Berman A (2000). Herb-drug interactions. Lancet; 355:134–8. Gad SC (1982). A neuromuscular screen for use in industrial Toxicology. J Toxicol

Environ Health; 9: 691–704. Galluzzi S, Zanetti O, Binetti G, Trabucchi M, Frisoni GB (2000). Coma in a patient

with Alzheimer’s disease taking low dose trazodone and Ginkgo biloba. J Neurol Neurosurg Psychiatr; 68: 679–80.

Ganachari MS, Veeresh Babu, Katare S (2004). Neuropharmacology of an extract

derived from Centella asiatica. Pharmac Biol; 42: 246–52. Ganguly DK, Malhotra CL (1967). Some behavioural effects of an active fraction from

Herpestis monniera, Linn (Brahmi). Ind J Med Res; 55: 473–82. Ganzera M, Gampenrieder J, Pawar RS, Khan IA, Stuppner H (2004). Separation of the

major triterpenoid saponins in Bacopa monnieri by high-performance liquid chromatography. Anal Chim Acta; 516:149–54.

Garay S, Mahato SB, Ohtani K, Yamasaki K (1996). Dammarane-type triterpenoid

saponins from Bacopa monniera. Phytochem; 42: 815–20. Gardner DM, Shulman KI, Walker SE, Tailor SAN (1996). The making of a user

friendly MAOI diet. J Clin Psychiatr; 57: 99–104. Garner JP (2005). Stereotypies and other abnormal repetitive behaviors: potential

impact on validity, reliability, and replicability of scientific outcomes. ILAR J; 46: 106–17.

Gebhardt R, Hengstler JG, Muller D, Glockner R, Buenning P, Laube, B, et al (2003).

New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab Rev; 35: 145–213.

Gentsch C, Lichtsteiner M, Feer H (1988). Competition for sucrose-pellets in triads of

male Wistar rats: the individuals' performances are differing but stable. Behav Brain Res; 27: 37–44.

Gillin JC, Buchsbaum M, Wu J, Clark C, Bunney W (2001). Sleep deprivation as a

model experimental antidepressant treatment: findings from functional brain imaging. Depress Anxiety; 14: 37–49.

Goel RK, Sairam K (2002). Anti ulcer drugs from indigenous sources with emphaisis

on musa sapientum, tamrabhasma, asparagus racemosus and zinzibar officinale. Ind J Pharmacol; 34:100–10.

Gohil KJ, Patel JA (2007). Herb-drug interactions: a review and study based on

assessment of clinical case reports in literature. Ind J Pharmacol; 39:129–39.

221

Gordon JB (1998). SSRIs and St. John’s wort: possible toxicity? Am Fam Phy; 57: 950. Gordon RY, Becker DJ, Rader DJ (2009). Reduced efficacy of rosuvastatin by St.

John's Wort. Am J Med; 122:e1–2. Gorka Z, Ossokova K, Stach R (1979). The effect of unilateral amygdala lesion on the

imipramine action in behaviour despair in rats. J Pharm Pharmacol; 31: 647–8. Gorka Z, Woitasik E (1980). The effect of antidepressants on the behavioural despair in

rats. Pol J Pharmacol Pharm; 32: 463–8. Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA (2004). The

effect of Echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther; 75: 89–100.

Govindarajan R, Vijayakumar M, Pushpangadan P (2005). Antioxidant approach to

disease management and the role of ‘Rasayana’ herbs of Ayurveda. J Ethnopharmacol; 99: 165–78.

Grant P (2004). Warfarin and cranberry juice: an interaction? J Heart Valve Dis; 13:25–

6. Grimaldi R, De Ponti F, D’ Ángelo L, Caravaggi M, Guidi G, Lecchini S, et al (1990).

Pharmacokinetics of the total triterpenic fraction of Centella asiatica after single and multiple administrations to healthy volunteers. A new assay for asiatic acid. J Ethnopharmacol; 28: 235–41.

Gupta AP, Mathur S, Gupta MM, Sushil KW (1998). Effect of drying on the bacoside:

A content of the harvested Bacopa monniera shoots revealed using a new High performance thin layer chromatography. J Med Aromat Plant Sci; 20:1052–5.

Gupta RK, Balasubrahmanyam L (1998). The Turmeric effect: World patent

Information; 20: 185–91. Gupta YK, Veerendra Kumar MH, Srivastava AK (2003). Effect of Centella asiatica

on pentylenetetrazole-induced kindling, cognition and oxidative stress in rats. Pharmacol Biochem Behav; 74: 579–85.

Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Carrier J, et al

(2004). In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Therap; 76: 428–40.

Hajos M, Fleishaker JC, Filipiak-Reisner JK, Brown MT, Wong EH (2004). The

selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. CNS Drug Rev; 10: 23-44.

Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ (2003). The

interaction between St. John’s wort and an oral contraceptive. Clin Pharmacol Ther; 74: 525–35.

Hall CS (1934). Emotional behavior in the rat. defecation and urination as measures of

individual differences in emotionality. J Comp Psychol; 18: 385–403. Halliday MS (1967). Exploratory behaviour in elevated mazes. The Quart J Exp

Psychol; 19: 254–63.

222

Harro J (2004). Animal models for better antidepressants: can pathogenetic approaches

can make a difference. Preclinica; 2:402–7. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV (2008). Curcumin: from ancient

medicine to current clinical trials. Cell Mol Life Sci; 65: 1631–52. Hausen BM (1993). Centella asiatica (Indian pennywort), an effective therapeutic but a

weak sensitizer. Contact Dermatitis; 29:175–9. Heck AM, DeWitt BA, Lukes AL (2000). Potential interactions between alternative

therapies and warfarin. Am J Health Syst Pharm; 57: 1221–27. Heidari M, Jamshedi AH, Akhondzadeh Sh, Ghaffari NM, Sadeghi MR, Ghazi KM, et

al (2007). Evaluating the effects of Centella asiatica on spermatogenesis in rats. Med J Reprod Infert; 7: 367–74.

Hellum BH, Hu Z, Nilsen OG (2009). Trade herbal products and induction of

CYP2C19 and CYP2E1 in cultured human hepatocytes. Basic Clin Pharmacol Toxicol; 105: 58–63.

Henn FA, Vollmayr B (2005). Stress models of depression: forming genetically

vulnerable strains. Neurosci Biobehav Rev; 29: 799–804. Herman ZS, Plech A, Bien E, Wieloch-Depta L, Jez W (1981). Effect of

cholinomimetics, Cholinolytics and atypical antidepressants in the behavioural despair test in the rat. Pol J Pharmacol Pharm; 33: 485–9.

Hermans K, Stockman D, Van den Branden F (2003). Grapefruit and tonic: a deadly

combination in a patient with the long QT syndrome. Am J Med; 114:511–2. Hilakivi LA, Lister RG (1990). Correlations between behaviour of mice in Porsolt’s

swim test and in tests of anxiety, locomotion and exploration. Behav Neural Biol; 53: 153–9.

Holcomb LA, Dhanasekaran M, Hitt AR, Young KA, Riggs M, Manyam BV (2006).

Bacopa monniera extract reduces amyloid levels in PSAPP mice. J Alzheimers Dis; 9: 243–51.

Holcomb SS (2009). Common herb-drug interactions: what you should know? The

Nurse Practition; 34: 21–9. Holm KJ, Spencer CM (1999). Reboxetine: a review of its use in depression. CNS

Drugs; 12:65–83. Holman CP, Bell AFJ (1983). A trial of evening primrose oil in the treatment of

chronic schizophrenia. J Orthomol Psychiatr; 12:302–4. Holmes PV (2003). Rodent models of depression: re-examining validity without

anthropomorphic interference. Crit Rev Neurobiol; 15:143–74. Holmes PV, Davis RC, Masini CV, Primeaux SD (1998). Effects of olfactory

bulbectomy on neuropeptide gene expression in the rat olfactory/limbic system. Neurosci; 86: 587–96.

Hota SK, Barhwal K, Baitharu I, Prasad D, Singh S, Ilavazhagan G (2009). Bacopa

monniera leaf extract ameliorates hypobaric hypoxia induced spatial memory impairment. Neurobiol Disease; 34: 23–39.

223

Hou CC, Lin SJ, Cheng, JT, Hsu FL (2002). Bacopaside III, bacopasaponin G, and

bacopasides A, B, and C from Bacopa monniera. J Nat Prod; 65: 1759–63. Hozl J, Godau P (1989). Receptor binding studies with Valeriana officinalis on the

benzodiazepine receptors. Planta Med; 55:64. Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, et al (2005). Herb-drug

interactions: a literature review. Drugs; 65:1239–82. Husain GM, Mishra D, Singh PN, Rao ChV, Kumar V (2007). Ethnopharmacological

review of native traditional medicinal plants for brain disorders. Pharmacog Rev; 1: 20–8.

Ioannides C (2002). Pharmacokinetic interactions between herbal remedies and

medicinal drugs. Xenobiotica; 32: 451–78. IPCS (1986). Principles and methods for the assessment of neurotoxicity associated

with exposure to chemicals. Environmental Health Criteria. Document No. 601/986. Ireson, CR, Jones DJL, Orr S, Coughtrie MWH, Boocock DJ, Williams ML, et al

(2002). Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev; 11:105–11.

Isimer A, Basci NA, Bozkurt A, Kayaalp SO (1991). Effects of mobile phase

composition on the separation of catecholamines by liquid chromatography with electrochemical detection. J Islamic Acad Sci; 4:130–5.

Izzat M (1998). A taste of Chinese medicine. Ann Thorac Surg: 66: 941–2. Izzo AA (2004). Drug interactions with St. John’s wort (Hypericum perforatum): a

review of the clinical evidence. Int J Clin. Pharmacol Ther; 42: 139–48. Izzo AA, Borrelli F, Capasso R (2002). Herbal medicine: the dangers of drug

interaction. Trends Pharmacol Sci; 23: 358–9. Izzo AA, Di Carlo G, Borrelli F, Ernst E (2005). Cardiovascular pharmacotherapy and

herbal medicines: the risk of drug interactions. Int J Cardiol; 98: 1–14. Izzo AA, Ernst E (2001). Interactions between herbal medicines and prescribed drugs: a

systematic review. Drugs; 61: 2163–75. Izzo AA (2005). Herb-drug interactions: An overview of the clinical evidence. Fundam

Clin Pharmacol; 19:1–16. Jain P, Khanna NK, Trehan T, Pendse VK, Godhwani JL (1994). Anti-inflammatory

effects of an Ayurvedic preparation, Brahmi Rasayan, in rodents. Ind J Exp Biol; 32: 633–6.

Janetzky K, Morreale AP (1997). Probable interaction between warfarin and ginseng.

Am J Health Syst Pharm; 54: 692–3. Jayaprakasha GK, Rao LM, Sakariah KK (2002). Improved HPLC method for the

determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. J Agric Food Chem; 50: 3668–72.

Jayashree G, Muraleedhara KG, Sudarslal S, Jacob VB (2003). Anti-oxidant activity of

Centella asiatica on lymphoma-bearing mice. Fitoterapia; 74:431–4.

224

Jellin JM (1999) (ed.), In Natural Medicines Comprehensive database. Pharmacist’s

Letter Stockton: Therapeutic research Faculty. Jesberger JA, Richardson JS (1985). Animal models of depression: parallels and

correlates to severe depression in humans. Biol Psychiatr; 20: 764–84. Johne A, Schmider J, Brockmoller J, Stadelmann AM, Störmer E, Bauer S, et al (2002).

Decreased plasma levels of amitriptyline and its metabolites on co-medication with an extract from St. John’s wort (Hypericum perforatum). J Clin Psychopharmacol; 22: 46–54.

Johnson GA, Kupiecki RM, Baker CA (1980). Single isotope derivative

(radioenzymatic) methods in the measurement of catecholamines. Metab; 29: 1106–13.

Jones BD, Runikis AM (1987). Interaction of ginseng with phenelzine. J Clin

Psychopharmacol; 7: 201–2. Joss J, Leblond R (2000). Potentiation of warfarin anticoagulation associated with

topical methylsalicylate. Ann Pharmacother; 34:729–33. Jyoti A, Sharma D (2006). Neuroprotective role of Bacopa monniera extract against

aluminium-induced oxidative stress in the hippocampus of rat brain. Neurotoxicol; 27: 451–7.

Kadhe NG, Chillar AJ, Deshmukh YA (2003). Reboxetine: a novel antidepressant. J

Postgrad Med; 49: 373–5. Kagedal B, Goldstein DS (1988) Catecholamine and their metabolites. J Chromatogr;

429:177–233. Kapoor R, Srivastava S, Kakkar P (2008). Bacopa monnieri modulates antioxidant

responses in brain and kidney of diabetic rats. Environ Toxicol Pharmacol (article in press).

Kar A, Panda S, Bharti S (2002). Relative efficacy of three medicinal plant extracts in

the alteration of thyroid hormone concentrations in male mice. J Ethnopharmacol; 81: 281–5.

Karolewicz B, Paul IA (2001). Group housing of mice increases immobility and

antidepressant sensitivity in the forced swim and tail suspension tests. Eur J Pharmacol; 415: 197–201.

Kartnig T (1986). Clinical applications of Centella asiatica (L) urb. In: Herbs, spices,

and medicinal plants: recent advances in botany, horticulture, and pharmacology, Craker LE, Simon JE (eds.), vol. 3. Phoenix, AZ: Oryx Press.p. 145–73.

Kartnig T (1988). Clinical applications of Centella asiatica (L.) Urb. Herbs spices and

medicinal plants, vol 3 .p.146–73. Katz RJ, Roth KA, Carol BJ (1981). Acute and chronic stress effect on open filed

activity in rats: implications for a model of depression. Neurosci, Biobehav Rev; 5: 247–51.

Katz RJ (1981a). Animal models and human depressive disorders. Neurosci Biobehav

Rev; 5: 231–46.

225

Katz RJ (1981b). Animal model of depression: effects of electroconvulsive shock

therapy. Neurosci Biobehav Rev; 5: 273-77. Katz RJ (1982). Animal model of depression: pharmacological sensitivity of a hedonic

deficit. Pharmacol Biochem Behav; 16: 965-8. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002). Recent

patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA; 287: 337–44.

Kaur G, Kulkarni SK (2000). Comparative study of antidepressants and herbal

psychotropic drugs in a mouse model of chronic fatigue. J Chronic Fatigue Syndr; 6; 23–35.

Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, et al (1999).

Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res; 59: 597–601.

Kelliher P, Connor TJ, Harkin A, Sanchez C, Kelly JP, Leonard BE (2000). Varying

responses to the rat forced-swim test under diurnal and nocturnal conditions. Physiol Behav; 69: 531–39.

Kent JM (2000). SNaRIs, NaSSAs and NaRIs: new agents for the treatment of

depression. Lancet; 355: 911–8. Khan IA (2006). Issues related to botanicals. Life Sci; 78: 2033–38. Khan R, Krishnakumar A, Paulose CS (2008). Decreased glutamate receptor binding

and NMDA R1 gene expression in hippocampus of pilocarpine-induced epilepticrats: Neuroprotective role of Bacopa monnieri extract. Epilepsy Behav; 12: 54–60.

Khawaja IS, Marotta RF, Lippmann S (1999). Herbal medicines as a factor in delirium.

Psychiatr Serv; 50: 969–70. Kirby LG, Lucki I (1997). Interaction between the forced swimming test and fluoxetine

treatment on extracellular 5-hydroxytryptamine and 5 hydroxyindoleacetic acid in the rat. J Pharmacol Exp Ther; 282: 967–76.

Kirtikar KR, Basu BD (1918). Indian Medicinal Plants, part II, Ind press, Allahabad, .p.

930–1. Kitada Y, Miyauchi T, Kanazawa Y, Nakamichi H, Satoh S (1983). Involvement of α-

and ß1 adrenergic mechanisms in immobility reducing action of desipramine in the forced swimming test. Neuropharmacol; 22: 1055–60.

Klaassen CD (2001). Casarett and Doull's Toxicology, the basic science of poisons, 6th

edition, McGraw-Hill. New York. Klepser T.B., Doucette W.R., Horton M.R. Buys LM, Ernst ME, Ford JK, et al (2000).

Assessment of patients’ perceptions and beliefs regarding herbal therapies. Pharmacotherap; 20: 83–7.

Kline KL (2000). Complementary and alternative medicine for neurologic disorders.

Clin Tech in Small Ani Prac; 17: 25–33.

226

Knapp DJ, Sim-Selley LJ, Breese GR, Overstreet DH (2000). Selective breeding of 5-

HT (1A) receptor-mediated responses: application to emotion and receptor action. Pharmacol Biochem Behav; 67: 701–8.

Kohen R, Neumaier JF, Hamblin MW, Edwards E (2003). Congenitally learned

helpless rats show abnormalities in intracellular signaling. Biol Psychiatr; 53: 520–9. Kohli K, Ali J, Ansari MJ, Raheman Z (2005). Curcumin: a natural antiinflammatory

agent. Ind J Pharmacol; 37:141–7. Kontur P, Dawson R, Monjan A (1984). Manipulation of the mobile phase parameters

for the HPLC separation of endogenous monoamines in rat brain tissue. J Neurosci Meth; 11:5–18.

Koolhaas JM, Schurmann T, Wiepkema PR (1980). The organization of intraspecific

agonistic behaviour in the rat. Prog Neurobiol; 15: 247–68. Kosuge T, Ishida, H. and Yamazaki, H (1985). Studies on active substances in the herbs

used for oketsu (“stagnant blood”) in Chinese medicine. III. On the anticoagulant principles in curcumae rhizome. Chem Pharm Bull (Tokyo); 33: 1499–1502.

Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, et al (1998).

Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Sci (Wash DC); 281: 1640–45.

Kuhn MA (2002). Herbal remedies: herb-drug interactions. Crit Care Nur; 22:22–32. Kulkarni SK (1999). Handbook of experimental pharmacology, 3rd edition, Vallabh

Prakashan, New Delhi. p.117–9. Kulshreshtha, DK, Rastogi RP (1974). Bacogenin A2: a new sapogenin from bacosides.

Phytochem; 13: 1205–6. Kulshreshtha, DK, Rastogi P (1973). Bacogenin A1: a novel dammerane triterpene

sapogenin from Bacopa monniera. Phytochem; 12: 887–92. Kumar V (2006). Potential medicinal plants for CNS disorders: an overview. Phytother

Res; 20: 1023–35. Lambrecht JE, Hamilton W, Rabinovich A (2000). A review of herb-drug interactions:

Documented and theoretical. US Pharma; 25: 8. Lantz MS, Buchalter E, Giambanco V (1999). St. John’s wort and antidepressant drug

interactions in the elderly. J Geriatr Psychiatr Neurol; 12: 7–10. Latane B (1969). Gregariousness and fear in laboratory rats. J Exp Social Psychol; 5:

61–9. Lathe R (2004). The individuality of mice. Genes Brain Behav; 3:317–27. Le Moal M, Simon H (1991). Mesocorticolimbic dopaminergic network: functional and

regulatory roles. Physiol Rev; 71: 155–234. Lee HS (2005). Antiplatelet property of curcuma longa L. rhizome-derived ar-

turmerone. Bioresource Technol (article in press).

227

Lee MK, Kim SR, Sung SH, Lim D, Kim H, Choi H, et al (2000). Asiatic acid

derivatives protect cultured cortical neurons from glutamate-induced excitotoxicity. Res Commun Mol Pathol Pharmacol; 108:75–86.

Leith NJ, Barrett RJ (1980). Effects of chronic amphetamine or reserpine on self-

stimulation: animal model of depression? Psychopharmacol; 72: 9–15. Lester D (1968). Two tests of a fear-motivated theory of exploration. Psychon Sci; 10:

385–6. Leung A (1980). Encyclopedia of common natural ingredients used in food, drugs, and

cosmetics. New York, NY: John Wiley.p. 313–4. Lin JK, Pan MH, Lin-Shiau SY (2000). Recent studies on the biofunctions and

biotransformations of curcumin. Biofact; 13:153–8. Lininger SW (2000). A-Z guide to drug-herb-vitamin interactions. Prima Health,

Rocklin, CA. Lorke D (1983). A new approach to practical acute toxicity testing. Arch Toxicol; 54:

275–89. Loya AM, Gonzalez-Stuart A, Rivera JO (2009). Prevalence of polypharmacy,

polyherbacy, nutritional supplements use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study. Drugs aging; 26: 423–36.

Lucas KH (2006). Interactions of CAM and prescription heart medications. US Pharm;

8:66–76. Lucki I (1997). The forced swimming test as a model for core and component

behavioral effects of antidepressant drugs. Behav Pharmacol; 8: 523–32. MacGregor JT, Collins JM, Sugiyama Y, Tyson CA, Dean J, Smith L, et al (2001). In

vitro human tissue models in risk assessment: report of a consensus-building workshop. Toxicol Sc; 59:17–36.

Maier SF, Seligman MEP (1976). Learned helplessness theory and evidence. J Exp

Psychol; 105: 3–46. Maier SF, Watkins LR (2005). Stressor controllability and learned helplessness: the

roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev; 29: 829–41.

Malhotra CK, Das PK (1959). Pharmacological studies of Herpestis monniera Linn

(Brahmi). Ind J Med Res, 47: 294–305. Manciocco A, Chiarotti, A, Vitale A, Calamandrei, G, Laviola G, Alleva E (2009). The

application of Russell and Burch 3R principle in rodent models of neurodegenerative disease: the case of Parkinson’s disease. Neurosci Biobehav Rev; 33:18–32.

Manji HK, Drevets WC, Charney DS (2001). The cellular neurobiology of depression.

Nature Med; 7: 541–7. Mannel M (2004). Drug interactions with St. John’s wort. Mechanisms and clinical

implications. Drug Saf; 27: 773–97.

228

Manzi SF, Shannon MM (2005). Drug interactions—a review. Clin Ped Emerg Med; 6:

93–102. Markou A (2005). Animal models of depression and antidepressant activity. Neurosci

Biobehav Rev; 29; 501–9. Markowitz JS, DeVane CL (2001). The emerging recognition of herb-drug interactions

with a focus on St. John’s wort (Hypericum perforatum). Psychopharmacol Bull; 35 53–64.

Markowitz JS, Devane CL, Chavin KD, Taylor RM, Ruan Y, Donovan JL (2003b).

Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin Pharmacol Ther; 74:170–7.

Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS (2004). Effect

of St. John’s wort on drug metabolism by induction of cytochrome p450 3A4 enzyme. Obstet Gynecol Surv; 59: 358–9.

Markowitz JS, Donovan JL, Devane CL, Taylor RM, Ruan Y, Wang JS (2003c).

Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin Pharmacol Ther; 74: 536–42.

Markowitz JS, Donovan JL, DeVane CL, Sipkes L, Chavin KD (2003a). Multiple-dose

administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. J Clin Psychopharmacol; 23: 576–81.

Martin E. Keck ME, Ohl F, Holsboer F, Mu¨ller MB (2005). Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neurosci Biobehav Rev; 29: 867–89.

Martin P, Soubrie P, Simon P (1987). The effect of monoamine oxidase inhibitors

compared with classical tricyclic antidepressants on leaned helplessness paradigm. Prog Neuropsychopharmacol Biol Psychiatr; 11: 1–7.

Martis G, Rao A, Karanth KS (1992). Neuropharmacological activity of Herpestis

monniera. Fitoterapia; 63: 399–404. Mathews JM, Etheridge AS, Black SR (2002). Inhibition of human cytochrome P450

activities by kava extract and kavalactones. Drug Metab Dispos; 30:1153–57. Mathews M (1998). Association of Ginkgo biloba with intracerebral hemorrhage

[Letter]. Neurol; 50:1933–34. Mathur A (2003). Who owns traditional knowledge? Working Paper No. 96, Indian

Council for Research on International Economic Relations. p. 1–33. Matthews K, Christmas D, Swan J, Sorrell E (2005). Animal models of depression:

navigating through the clinical fog. Neurosci Biobehav Rev; 29: 503–13. McKinney WT, Bunney WE (1969). Animal model of depression I. Review of

evidence: implications for research. Arch Gen Psychiatr; 21: 240–8. Mcnamara BP (1976). Concepts in health evaluation of commercial and industrial

chemical in: Menlman MA, Snapiro RE, Blumenthal H (eds.) New concepts in safety evaluation, Hemisphere, Washington DC.

229

Mefford IN (1981). Application of high performance liquid chromatographic

electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J Neurosci Meth; 3:207–24.

Menninni T, Bernasconi P, Bombardelli E Morazzoni P (1993). In vitro studies on the

interactions of extracts and pure compounds from Valeriana officinalis roots with GABA, benzodiazepine and barbiturate receptors. Fitoterapia; 64: 291–300.

Meyer OA, Tilson HA, Byrd WC, Riley MT (1979). A method for the routine

assessment of fore- and hind limb grip strength of rats and mice. Neurobehav Toxicol; 1:233–6.

Meyer SE, Chrousos GP, Gold PW (2001). Major depression and the stress system: a

life span perspective. Dev Psychopathol; 13: 565–80. Miller LG (1998). Herbal medicinals: selected clinical considerations focusing on

known or potential drug-herb interactions, Arch Int Med; 158: 2200–11. Mitchell PJ, Redfern PH (2005). Animal models of depressive illness: the importance

of chronic drug treatment. Curr Pharmac Design; 11: 171–203. Mitchell PJ (1993). Ethological studies of the social behaviour of the rat. Animal

Technol; 44: 105–17. Monograph (2007) Centella asiatica. Monographs for herbal medicinal products.

Available from: http://www.mohp.gov.eg/Sec/Statistics/hplants.pdf (Consulted, May 12, 2008).

Monograph (2004). Bacopa Monniera. Alt Med Rev; 9: 79–85. Monograph (2001). Curcuma longa (Turmeric). Alt Med Rev; 6: S62–S6. Monroe SM, Thase ME, Hersen M, Himmelhochh LM, Bellack AS (1985). Life events

and the endogenous-nonendogenous distinction in the treatment and post-treatment course of depression. Compr Psychiatr; 26: 175–86.

Montgomery KC (1955). The relationship between fear induced by novel stimulation

and exploratory behavior. J Comp Physiol Psychol; 48: 254–60. Montgomery SA (1999). Predicting response: noradrenaline reuptake inhibition. Int

Clin Psychopharmacol; 14: S21–6. Mook-Jung I, Shin JE, Yun SH, Huh K, Koh JY, Park HK, et al (1999). Protective

effects of asiaticoside derivatives against beta-amyloid neurotoxicity. J Neurosci Res; 58: 417–25.

Morilak DA, Frazer A (2004). Antidepressants and brain monoaminergic systems: A

dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int J Neuropsychopharmacol; 7: 193–218.

Morpugo C (1971). A new design for the screening of CNS active drugs in mice.

Arzeim- Forsch (Drug Res); 21:1727. Mortellini R, Foresti R, Bassi R, Green CJ (2000). Curcumin, an antioxidant and anti-

inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med; 28:1303–12.

230

Moser VC, Mc Daniel KM, Philips PM (1991). Rat strain and stock comparisons using

a functional observational Battery: baseline value and effects of amitraz. Toxicol Appl Pharmacol; 108: 267-83.

Motterlini R, Foresti R, Bassi R, Green CJ (2000). Curcumin, an antioxidant and anti-

inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radi Biol Med; 28:1303–12.

Mukherjee DG, Dey CD (1966). Clinical trial on brahmi. Ind J Exp Med Sci; 10: 5–11. Murphy Dl (1990). Neuropsychiatric disorders and the multiple human brain serotonin

receptor sub types and subsystems. Neuropsychopharmacol; 3: 457–71. Murray CJ, Lopez AD (1997). Alternative projections of mortality and disability by

cause 1990-2020: global burden of disease study. Lancet; 349:1498–504. Muscat R, Papp M, Willner P (1992). Reversal of stress-induced anhedonia by the

atypical antidepressants, fluoxetine and maprotiline. Psychopharmacol (Berl); 109: 433–8.

Mycek MJ, Harvey RA, Champe PC (2000). Lippincott’s illustrated reviews:

Pharmacology, 2nd edition, Lippincott Williams and Wilkins. Mythilypriya R, Shanthi P, Sachdanandam P (2007). Oral acute and subacute toxicity

studies with Kalpaamruthaa, a modified indigenous preparation on rats. J Health Sci; 53: 351–8.

Nadkarni KM (1988). The Indian Materia Medica. Columbia, MO: South Asia Books.

p. 624–5. Nagai M, Fukamachi T, Tsujimoto M, Ogura, K, Hiratsuka A, Ohtani H, et al (2009).

Inhibitory effects of herbal extracts on the activity of human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3). Biol Pharmaceutical Bull; 32:105–09.

Nagy ZM, Holm M (1970). Open field behaviour of C3H mice: effect of early

handling, field illumination and age at testing. Psychonomic Sci; 19: 273–4. Nalini, K (1992). Effect of Centella asiatica fresh leaf aqueous extract on learning and

memory and biogenic amine turnover in albino rats. Fitoterapia; 63:232–7. Nancy Y, Pang THH (2008). Recent development in the search for effective

antidepressants using traditional Chinese medicine. Cent Nerv Sys Agents Med Chem; 8: 64–71.

Nathan PJ, Clarke J, Lloyd J, Hutchinson CW, Downey L, Stough C (2001). The acute

effects of an extract of Bacopa monniera (brahmi) on cognitive function in healthy normal subjects. Hum Psychopharmacol; 16: 345–51.

Negi KS, Singh YD, Kushwaha KP, Rastogi CK, Rathi AK, Srivastava JS, et al (2000).

Clinical evaluation of memory enhancing properties of Memory Plus in children with attention deficit hyperactivity disorder. Ind J Psychiatr; 42: Supplement.

Nelson JC, Charney DS (1981). The symptoms of major depression. Am J Psychiatr;

138: 1–13.

231

Nestler, EJ, Gould EG, Manji, H, Buncan M, Duman RS, Greshenfeld HK, et al (2002).

Preclinical models: status of basic research in depression. Biol Psychiatr; 52: 503–28. Nishizuka Y (1992). Intracellular signaling by hydrolysis of phospholipids and

activation of protein kinase C. Sci; 258: 607–14. Nivitabishekam, SN, Asad, M, Prasad, VS (2009). Pharmacodynamic interaction of

Momordica charantia with rosiglitazone in rats. Chemico-Biol Interactions; 177: 247–53.

Norman TR, Burrows GD (2007). Emerging treatments for major depression. Expert

Rev Neurother; 7: 203–13. Nowack R (2008). Herb-drug interactions in nephrology. Clin Nephrol; 69: 319–25. Nutt, DJ (2006). The role of dopamine and norepinephrine in depression and

antidepressant treatment. J Clin Psychiatr; 67: 3–8. O’Neil MF, Moore NA (2003). Animal models of depression: are there any? Hum.

Psychopharmacol; 18: 239–54. Obach RS (2000). Inhibition of human cytochrome P450 enzymes by constituents of St.

John’s wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther; 294:88–95.

Olin BR (ed.) (1990). Facts and comparisons. The Lawrence review of natural

products: Ginseng, on validity, reliability, and replicability of scientific outcomes. ILAR J 2005; 46; 106–117.

Overmier JB, Seligman MEP (1967). Effects of inescapable shock upon subsequent

escape and avoidance learning. J Comp Physiol Psychol; 63: 28–33. Overstreet DH, Elliot Friedman E, Mathe´ A, Yadid G (2005). The Flinders Sensitive

Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev; 29: 739–59.

Overstreet DH (2002). Behavioral characteristics of rat lines selected for differential

hypothermic responses to cholinergic or serotonergic agonists. Behav Genet; 32: 335–48.

Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I (1999). Serotonergic mediation of the

effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacol (Berl.); 147:162–7.

Paget GE, Barnes JM (1964). Toxicity tests. In: Evaluation of drug activities:

Pharmacometrics, Laurence DR, Bacharach AL (eds.), Vol 1, London: Academic Press. p. 135.

Pal D, Mitra AK (2006). MDR- and CYP3A4-mediated drug-herbal interactions. Life

Sci; 78: 2131–45. Pal R, Dwivedi AK, Singh S, Kulshrestha DK (1998). Quantitative determination of

bacoside by HPLC. Ind J Pharma Sci; 60: 328–9. Pal R, Sarin JPS (1992). Quantitative determination of bacosides by UV-

spectrophotometry. Ind J Pharma Sci; 54: 17–8.

232

Panossian A, Hovhannisyan A, Abrahamyan H, Gabrielyan E, Wikman G (2009).

Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats. Phytother Res; 23: 351–57.

Parmar V (2005). Herbal medicines: its toxic effects and drug interactions. The Indian

Anaesthetists’ Forum – (www.theiaforum.org) .p. 1-9 (Consulted, June 15, 2006). Patel JA, Gohil KJ (2008). Warfarin-herb interactions: a review and study based on

assessment of clinical case reports in literature. Bol Latinoam del caribe de plantas med y Aromat; 7: 85–99.

Pathania V, Gupta AP, Singh B (2006). Improved HPTLC method for determination of

curcuminoids from Curcuma longa. J Liq Chromat Rel Tech; 29: 877–87. Pawar R, Gopalakrishnan C, Bhutani KK (2001). Dammarane triterpene saponin from

Bacopa monniera as the superoxide inhibitor in polymorphonuclear cells. Planta Med; 67: 752–4.

Pawlak CR, Ho Y, Schwarting RKW (2008). Animal models of human

psychopathology based on individual differences in novelty-seeking and anxiety. Neurosci Biobehav Rev; 32: 1544–68.

Pekthong D, Blanchard N, Abadie C, Bonet A, Heyd B, Mantion G, et al (2009).

Effects of Andrographis paniculata extract and Andrographolide on hepatic Cytochrome P450 mRNA expression and monooxygenase activities after in vivo administration to rats and in vitro in rat and human hepatocyte cultures. Chemico-biol interactions; 179: 247–55.

Perlman BB (1990). Interaction between lithium salts and ispaghula husk. Lancet; 17:

335: 416. Pineyro G, Blier P (1999). Autoregulation of serotonin neurons: role in antidepressant

drug action. Pharmacol Rev; 51: 533– 91. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J (2000). Indinavir

concentrations and St. John’s wort. Lancet; 355: 547–8. Platt JE, Stone EA (1982). Chronic restraint stress elicits a positive antidepressant

response on the forced swim test. Eur J Pharmacol; 82: 179–81. Poppenga RH (2002). Herbal medicine: potential for intoxication and interactions with

conventional drugs. Clin Tech in Small Anim Prac; 17: 6–18. Porsolt RD, Anton G, Blavet N, Jalfre M (1978a). Behavioural despair in rats: a new

model sensitive to antidepressant treatments. Eur J Pharmacol; 47: 379–91. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979). Immobility induced by

forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol; 57: 201–10.

Porsolt RD, Bertin A, Jalfre M (1977b). Behaviour despair in mice: a primary screening

test for antidepressants. Arch Int Pharmacodyma Ther; 229: 327–36. Porsolt RD, Bertin A, Jalfre M (1978b). Behavioural despair in rats and mice: strain

differences and the effects of imipramine. Eur J Pharmacol; 51: 291–94.

233

Porsolt RD, Le Pichon M, Jalfre M, Chatterjee SS (1977a). Depression: a new animal

model sensitive to antidepressant treatments. Nature; 266:730–32. Porsolt RD, Chermat R, Lenegre A, Avril I, Janvier S, Steru L (1987). Use of the

automated tail suspension test for the primary screening of psychotropic agents. Arch Int Pharmacodyn Ther; 288:11–30.

Prakash JC, Sirsi M (1962). Comparative study of the effects of Brahmi (Bacopa

monniera) and chlorpromazine on learning in rats. J Sci Indust Res; 21: 93–6. Prakash O, Singh GN, Singh RM, Mathur SC, Bajpai M, Yadav S (2008).

Determination of bacoside A by HPTLC in Bacopa monnieri extract. Int J Green Pharm; 2: 173–5.

Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF (2007).

Effect of Fagonia Arabica (Dhamasa) on in vitro thrombolysis. BMC Compl Alt Med; 7: 36.

Prost N, Tichadou L, Rodor F, Nguyen N, David JM, Jean- Pastor MJ (2000). St.

John’s wort-venlafaxine interaction. Presse Med; 29: 1285–86. Pyevich D, Bogenschutz MP (2001). Herbal diuretics and lithium toxicity. Am J

Psychiatr; 158: 1329. Rafatulla S, Tariq M, Alyahya MA, Mossa JS, Ageel AM (1990). Evaluation of

turmeric (Curcuma longa) for gastric and duodenal antiulcer activity in rats. J Ethnopharmacol; 29: 25–34.

Rafferty AP, McGee HB, Miller CE, Reyes M (2002). Prevalence of complementary

and alternative medicine use: state-specific estimates from the 2001. Am J Pub Health; 92: 1598–1600.

Raghav S, Singh H, Dalal PK, Srivastava JS, Asthana OP (2006). Randomized

controlled trial of standardized Bacopa monniera extracts in age-associated memory impairment. Ind J Psychiatry; 48: 238–42.

Rai D, Bhatia G, Palit G, Pal R, Singh S, Singh H (2003). Adaptogenic effect of

Bacopa monniera (Brahmi). Pharmacol Biochem Behav; 75: 823–830. Rajpal V (2002). Standardization of botanicals, vol 1. Eastern Publishers, New Delhi,

India. p. 66-76; 120–136. Ramakrishnappa K (2003). Biodiversity and the ecosystem approach in agriculture,

forestry and fisheries. New York, USA: Impact of Cultivation and Gathering of Medicinal Plants on Biodiversity: Case studies from India. United Nations Publications. p. 210–5.

Ramaswamy AS, Pariyaswami SM, Basu N (1970). Pharmacological Studies on

Centella asiatica. Linn. Ind J Med Res; 4:160–4. Ramirez-Tortosa MC, Mesa MD, Aguilera MC, Quiles JL, Baró L, Ramirez-Tortosa

CL, et al (1999). Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis; 147:371–78.

Rang HP, Dale M, Ritter J (2001). Pharmacology, 4th edition, New York: Churchill

Livingstone.

234

Rao ChV, Sairam K, Goel RK (2000). Experimental evaluation of Bacopa monniera on

rat gastric ulceration and secretion. Ind J Physiol Pharmacol; 44: 435–41. Rao U, Chen LA (2008). Neurobiological and psychosocial processes associated with

depressive and substance-related disorders in adolescents. Curr Drug Abuse Rev; 1: 68–80.

Rastogi S, Pal R, Kulshreshtha, DK (1994). Bacoside A3-a triterpenoid saponin from

Bacopa monniera. Phytochem; 36:133–7. Rastogi, RP (1990). Compendium of Indian Medicinal Plants, vol. 1. CSIR, New Delhi.

p. 118–22. Rasyid A, Lelo A (1999). The effect of curcumin and placebo on human gall bladder

function: an ultrasound study. Ailment Pharmacol Ther; 13: 245–9. Raum WJ (1984). Methods of plasma catecholamine measurement including

radioimmunoassay. Am J Physiol; 24: E4–IZ. Ravindranath V, Candrashekara N (1982). Metabolism of curcumin - studies with (3H)-

curcumin. Toxicol; 22: 337–44. Renukappa T, Roos G, Klaiber I, Vogler B, Kraus W (1999). Application of high

performance liquid chromatography coupled to nuclear magnetic resonance spectrometry, mass spectrometry and bioassay for the determination of active saponins from Bacopa monniera Wettst. J Chromat Anal; 247: 109–16.

Rethy CR, Smith CB, Villarreal JE (1971). Effects of narcotic analgesics upon the

locomotor activity and brain catecholamine content of the mouse. J Pharmacol Exp Ther; 176: 472–9.

Rezvani, AH, Parsian, A, Overstreet, DH (2002). The Fawn-Hooded (FH/Wjd) rat: a

genetic animal model of co-morbid depression and alcoholism. Psychiatr Genet; 12: 1–16.

Rindone J, Murphy T (2006). Warfarin-cranberry juice interaction resulting in profound

hypoprothrombinemia and bleeding. Am J Ther; 13: 283–4. Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH (2000). St. John’s wort:

effect on CYP3A4 activity. Clin Pharmacol Ther; 67: 451–7. Rode D (2002). Comfrey: toxicity revisited. Trends Pharmacol Sc; 23: 497–9. Rodeiro I, Donato MT, Jimenez N, Garrido G, Molina-Torres J, Menendez R, et al

(2009). Inhibition of human CYP450 enzymes by natural extracts used in traditional medicine. Phytother Res; 23: 279–82.

Rohini G, Sabitha KE, Devi CS (2004). Bacopa monniera Linn. extract modulates

antioxidant and marker enzyme status in fibrosarcoma bearing rats. Ind J Exp Biol; 42: 776–80.

Rommel GT, Richard BK (2009). Nuclear receptors and drug-drug interactions with

prescription and herbal medicines. In: Nuclear receptors in drug metabolism. Wen X (ed.), The University of Western Ontario, ON, Canada, John Wiley & Sons, Inc. p. 211–39.

235

Roodenrys A, Booth D, Bulzomi A, Phipps A, Micallef C, Smoker J (2002). Chronic

effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacol; 27: 279–81.

Rosado MF (2003). Thrombosis of a prosthetic aortic valve disclosing a hazardous

interaction between warfarin and a commercial ginseng product. Cardiol; 99:111. Rose KD, Croissant PD, Parliment CF, Levin MB (1990). Spontaneous spinal epidural

hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurg; 26: 880–2.

Rosecrans R, Dohnal JC (2009). The effect of complimentary and alternative medicine

products on laboratory testing. Semin diag pathol; 26: 38–48. Rosenblatt M, Mindel J (1997). Spontaneous hyphema associated with ingestion of

Ginkgo biloba extract (letter). N Engl Med; 336: 1108. Roughley PJ, Whiting DA (1973). Experiments in the biosynthesis of curcumin. J

Chem Soc; 20: 2379–88. Rushton R, Steinberg H (1966). Combined effects of chlordiazepoxide and dexamphetamine on activity of rats in an unfamiliar environment. Nature (Lond.); 211: 1312–3. Rushton R, Steinberg H (1963). Mutual potentiation of amphetamine and

amylobarbitone measured by activity in rats. Br J Pharmacol Chemother; 21: 295–305.

Russo A, Borrelli F, Campisi, A, Acquaviva, R, Raciti G, Vanella A (2003a). Nitric

oxide-related toxicity in cultured astrocytes: effect of Bacopa monniera. Life Sci; 73: 1517–26.

Russo A, Borrelli. F (2005). Bacopa monniera, a reputed nootropic plant: an overview.

Phytomed; 12: 305–17. Russo A, Izzo, AA, Borrelli F, Renis M. Vanella A (2003b). Free radical scavenging

capacity and protective effect of Bacopa monniera L. on DNA damage. Phytother Res; 17: 870–5.

Sairam K, Rao CV, Babu MD, Goel RK (2001). Prophylactic and curative effects of

Bacopa monniera in gastric ulcer models. Phytomed; 8: 423–30. Sairam, K, Dorababu M, Goel RK, Bhattacharya SK (2002). Antidepressant activity of

standardized extract of Bacopa monniera in experimental models of depression in rats. Phytomed; 9: 207–11.

Sakina MR, Dandiya PC, Hamdard ME, Hameed A (1990). Preliminary

psychopharmacological evaluation of Ocimum sanctum leaf extract. J Ethnopharmacol; 28: 143–50.

Samiulla DS, Prashanth D, Amit A (2001). Mast cell stabilizing activity of Bacopa

monnieri. Fitoterapia; 72: 284–5. Sandford JJ, Argyropoulos SV, Nutt DJ (2000). The psychobiology of anxiolytic drugs:

Part I: Basic neurobiol Pharmacol Ther; 88: 197–212.

236

Sandoval MR, Palermo-Neto J (1995). Effect of manipulation of the GABA system on

dopamine-related behaviors. Braz J Med Biol Res; 28: 88–99. Sane RT, Patel PH, Phadke M (1998). Geographical variation study on gingerol (A

pungent principle from Zingiber officinale and ginger oil using HPTLC technique and accelerated stability study on gengerol from Zingiber officinale using HPTLC method. Ind drugs; 35: 1–37.

Sarter M, Bruno JP (2002). Animal models in biological psychiatry. In: Biological

psychiatry, D'haenen HAH, Den Boer JA, Willner P (eds.), Chichester, Wiley. p. 37-44.

Satyavati GV, Raina MK, Sharma M (1976). Medicinal plants of India, vol I. Indian

Council of Medical Research, New Delhi. p. 112–8. Saw JT, Bahari MD, Ang HH, Lim YH (2007). Potential drug-herb interactions with

antiplatelet/anticoagulant drugs. Complement Ther Clin Pract; 12: 236–241. Scatton B, Bartholini G (1982). Gamma-aminobutyric acid (GABA) receptor

stimulation. IV. Effect of progabide (SL 76002) and other GABAergic agents on acetylcholine turnover in rat brain areas. J Pharmacol Exp Ther; 220: 689-95.

Schelosky L, Raffauf C, Jendroska K, Poewe W (1995). Kava and dopamine

antagonism. J Neurol Neurosurg Psychiatr; 58: 639–40. Scott PA, Cierpial MA, Kilts CD, Weiss JM (1996). Susceptibility and resistance of

rats to stress-induced decreases in swim-test activity: a selective breeding study. Brain Res; 725: 217–30.

Seiss H (1993). Strategies of antioxidant defense. Eur J Biochem; 215: 213–9. Shader RI, Greenblatt DJ (1985). Phenelzine and the dream machine – ramblings and

reflections. J Clin Psychopharmacol; 5: 65. Shader RI, Greenblatt DJ (1995). Pharmacotherapy of acute anxiety. In

Psycopharmacology, Fourth generation of progress, Bloom FE, Kupfer, DJ (eds.), Raven Press, New York. p.1341–48.

Shankar G, Singh HK (2000). Anxiolytic profile of standardized Brahmi extract. Ind J

Pharmacol; 32: 152. Shanmugasundaram ER, Akbar GK, Shanmugasundaram, Brahmighritham KR (1991).

An Ayurvedic herbal formula for the control of epilepsy. J Ethnopharmacol; 33: 269–76.

Sharma R, Chaturvedi C, Tewari PV (1987). Efficacy of Bacopa monnieri in

revitalizing intellectual functions in children. J Res Edu Ind Med; 1: 1–12. Shastri, MS, Dhalla, NS, Malhotra, CL (1959). Chemical investigation of Herpestis

monniera Linn (Brahmi). Ind J Pharmacol; 21: 303–04. Shearman MS, Sekiguchi K, Nishizuka Y (1989). Modulation of ion channel activity: a

key function of the protein kinase C enzyme family. Pharmacol Rev; 41: 211–37.

237

Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P (1998). Influence of

piperine on the pharamacokinetics of curcumin in animals and human volunteers. Planta Med; 64: 353–6.

Shrikumar S, Ravi TK (2007). Approaches towards development and promotion of

herbal drugs. Pharmacog Rev; 1:180–4. Shrikumar S, Sandeep S, Ravi TK, Umamaheswari M (2004). A HPTLC determination

and fingerprinting of bacosides in Bacopa monnieri and its formulation. Ind J Pharm Sc; 66: 132–5.

Shukla B, Khanna NK, Godhwani JL (1987). Effect of brahmi rasayan on the central

nervous system. J Ethnopharmacol; 21: 65–74. Silberg WM, Lunberg GD, Musacchio RA (2007). Assessing, controlling and assuming

the quality of medical information on the internet: Caveant lector et viewer let the reader and viewer beware. JAMA; 277:1244–5.

Silver RJ. Ayurvedic veterinary medicine (1997). In: Complementary and alternative

veterinary medicine, Schoen AM, Wynn SG (eds.), St. Louis, MO: Mosby, Inc. p. 463–4.

Sing A, Kulkarni, Garg V, Gupta S, Kulkarni SK (2002). Role of antioxidants in

chronic fatigue test in mice. Ind J Exp Biol; 40:1240–44. Singh B, Rastogi RP (1969). A reinvestigation of the triterpenes of Centella asiatica.

Phytochem; 8: 917–21. Singh B, Tyagi A, De J, Agrawal S (2005). HPTLC determination of asiaticoside in

Centella asiatica (Linn) Ind drugs; 42:87–9. Singh HK, Dhawan BN (1982). Effect of Bacopa monnieri Linn. (Brahmi) extracts on

avoidance responses in rat. J Ethnopharmacol; 5: 205–8. Singh HK, Dhawan BN (1997). Neuropsychopharmacological effects of the Ayurvedic

nootropic Bacopa monniera Linn. (Brahmi). Ind J Pharmacol; 29: S359-65. Singh HK, Rastogi RP, Srimal RC, Dhawan BN (1988). Effect of bacosides A and B on

avoidance responses in rats. Phytother Res; 2: 70–5. Singh HK, Shanker G, Patnaik GK (1996). Neuropharmacological and anti-stress

effects of bacosides: a memory enhancer. Ind J Pharmacol; 28: 47. Singh P, Singh JS (2002). Recruitment and competitive interaction between ramets ans

seedlings in a perennial medicinal herb, Centella asiatica. Basic Appl Ecol; 3: 65-76. Singh RH, Singh L (1980). Studies on the anti-anxiety effect of the Medyha Rasayana

drug, Brahmi (Bacopa monniera Wettst.) – Part 1. J Res Ayur Siddha; 1:133–48. Singh S Eapen S, D'Souza. SF (2006). Cadmium accumulation and its influence on

lipid peroxidation and antioxidative system in an aquatic plant, Bacopa monnieri L. Chemosphere; 62: 233–46.

Singh A, Singh SK (2008). Evaluation of antifertality potential of brahmi in male

Mouse. Contraception (article in press).

238

Sinha MM (1971). Some empirical behavioral data indicative of concomitant

biochemical reactions. Proc Ind Sci Congr Part II, Banglore. p. 1–26. Slattery DA, Hudson, AL, Nutt DJ (2004). Invited review: the evolution of

antidepressant mechanisms. Fund Clin Pharmacol; 18:1–21. Slotkin TA, Miller DB, Fumagalli F, McCook EC, Zhang J, Bissette G, et al (1999).

Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats. J Pharmacol Exp Ther; 289: 334–45.

Smith DB (1991). Cognitive effects of anti-epileptic drugs. Adv Neurol; 55: 197–212. Soblosky JS, Thurmond JB (1986). Biochemical and behavioral correlates of chronic

stress: effects of tricyclic antidepressants. Pharmacol Biochem Behav; 24: 1361–8. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ (2002).

Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res; 62: 3868–75.

Sparreboom A, Cox MC, Acharya MR, Figg WD (2004). Herbal remedies in the United

States: potential adverse interactions with anticancer agents. J Clin Oncol; 22: 2489–503.

Spiacci A, Kanamaru F, Guimarães FS, Oliveira RM (2008). Nitric oxide-mediated

anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression. Pharmacol Biochem Behav; 88: 247–55.

Spinella M, Eaton LA (2002). Hypomania induced by herbal and pharmaceutical

psychotropic medicines following mild traumatic brain injury. Brain Inj; 16: 359–67. Srimal RC, Dhawan BN (1973). Pharmacology of diferuloyl methane (curcumin), a

non-steroidal anti-inflammatory agent. J Pharm Pharmacol; 25: 447–52. Srivastava R, Shukla YN, Kumar S (1997). Chemistry and pharmacology of Centella

asiatica: a review. J Med Arom Plant Sci; 19:1049–56. Stafford GI, Mikael E, Pedersen ME, Staden JV, Anna K, Jäger AK (2008). Review on

plants with CNS-effects used in traditional South African medicine against mental diseases. J Ethnopharmacol; 119: 513–37.

Steinberg R, Alonso R, Griebel G, Bert L, Jung M, Oury-Donat F, et al (2001).

Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function. J Pharmacol Exp Ther; 299: 449–58.

Stenzel-Poore MP, CameronVA, Vaughan J, Sawchenko PE, Vale W (1992).

Development of cushing’s syndrome in corticotropin releasing factor transgenic mice. Endocrinol; 130: 3378–86.

Steru L, Thierry BC, Simon P (1985). The tail suspension test: a new method for

screening antidepressants in mice. Psychopharmacol; 85: 367–70. Stough C, Lloyd J, Clarke J, Downey LA, Hutchison CW, Rodgers T, et al (2001). The

chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacol; 156: 481–4.

239

Stout JM (2006). Will alternative therapies work with warfarin? Available from:

http://ezinearticles.com/?Will-Alternative-zzTherapies-Work-Warfarin?&id=365346 (Consulted, June 9, 2007).

Strimpakos AS, Sharma RA (2008). Curcumin: preventive and therapeutic properties in

laboratory studies and clinical trials. Antioxidants & Redox Signaling; 10: 511–46. Sumathi T, Nayeem M, Balakrishna K, Veluchamy G, Devaraj SN (2002a). Alcoholic

extract of Bacopa monniera reduces the in vitro effects of morphine withdrawal in guineapig ileum. J Ethnopharmacol; 82: 75–81.

Sumathy T, Govindasamy S, Balakrishna K, Veluchamy G (2002b). Protective role of

Bacopa Monniera on morphine-induced brain mitochondrial enzyme activity in rats. Fitoterapia; 73: 381–5.

Sumathy T, Subramanian S, Govindasamy S, Balakrishna K, Veluchamy G (2001).

Protective role of Bacopa monniera on morphine induced hepatotoxicity in rats. Phytother Res; 15: 643–5.

Sunter WH (1991). Warfarin and garlic (Letter). Pharm J; 246: 722. Suvarna R, Pirmohamed M, Henderson L (2003). Possible interaction between warfarin

and cranberry juice. Br Med J; 327:1454. Tam L, Chan T, Leung W (1995). Coumadin interactions with Chinese traditional

medicines: danshen and methyl salicylate medicated oil (Letter). Aust NZ J Med; 25: 258.

Tang M, Larson-Meyer DE, Liebman M (2008). Effect of cinnamon and turmeric on

urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr; 87:1262–7.

Taylor J, Wilt V (1999). Probable antagonism of coumadin by green tea. Ann

Pharmacother; 33:426–8. Thai CH (2004). Herb-drug interactions. Ethnomed: 1-10 Available from:

http://ethnomed.org/clin_topics/herbal_medicine/herb-drug_rev.pdf (consulted, June 10, 2007).

Thiyagarajan M, Sharma SS (2004). Neuroprotective effect of curcumin in middle

cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci; 74: 969–85. Timbrel J (2002). Principals of biochemical Toxicology, 3rd edition, Tayor and Francis,

London, UK. Tindle HA, Davis RB, Phillips RS, Eisenberg DM (2005). Trends in the use of

complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med; 11: 42–9.

Toda S, Miyase T, Arich H, Tanizawa H, Takino Y (1985). Natural antioxidants:

antioxidative compounds isolated from rhizome of Curcuma longa L. Chem Pharmacol Bull; 33: 1725–28.

Tomlinson B, Hu M, Lee VW (2008). In vivo assessment of herb-drug interactions:

possible utility of a pharmacogenetic approach? Mol Nutr Food Res; 52:799–809.

240

Tovar RT (2009). Clinical approach to clinical herbal toxicity. Semin Diagn Pathol; 26:

28–37. Tripathi YB, Chaurasia S, Tripathi E, Upadhyay A, Dubey GP (1996). Bacopa

monniera Linn. as an antioxidant: mechanism of action. Ind J Exp Biol; 34: 523–6. Tupper DE, Wallace RB (1980). Utility of neurological examination in rats. Acta

Neurobiol; 40: 999–1003. Twarog BM, Page RH (1953). Serotonin content of some mammalian tissues and urine

and a method for its determination. Am J Physiol; 175:157–61. Tweddell P, Boyle C (2009). Potential interactions with herbal medications and

midazolam. Dental update; 36: 175–8. Udenfriend S, Weissbach H, Clark CT (1955a). The estimation of 5-hydroxytrytamine

(Serotonin) in biological tissues. J Biol Chem; 215: 337–44. Udenfriend SD, Bogdanski DF, Weissbach H (1955b). Fluorescence characteristics of

5-hydroxytryptamine (serotonin). Sci; 122: 972–3. Upadhyay SC, Khosa RL, Sharma DN, Kumar M, Chansauria JPN (1991). Total

glycoside content and antistress activity of Indian and Mauritius Centella asiatica- a comparison. Ind drugs; 28: 388–9.

Urani A, Roman FJ, Phan V, Su T, Maurice T (2001). The antidepressant-like effect

induced by α1-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. J Pharmacol Exp Ther; 298: 1269–79.

Vaidya AB (1997). The status and scope of Indian medicinal plants acting on central

nervous system. Ind J Pharmacol; 29: S340–3.

Vaugeois JM, Odievre C, Loisel L, Costentin J (1996). A genetic mouse model of helplessness sensitive to imipramine. Eur J Pharmacol; 316; R1–2.

Veerendra Kumar MH, Gupta YK (2003). Effect of Centella asiatica on cognition and

oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin Exp Pharmacol Physiol; 30:336–42.

Venkataramanan R, Komoroski B, Strom S (2006). In vitro and in vivo assessment of

herb-drug interactions. Life Sci; 78: 2105–15. Venkatesan N (1998). Curcumin attenuation of acute adriamycin myocardial toxicity in

rats. Br J Pharmacol; 1124: 425–7. Venkateswarlu S, Marellapudi, Ramachandra MS, Subbaraju GV (2005). Synthesis and

biological evaluation of polyhydroxycurcuminoids. Bioorg Med Chem (Article in press).

Vijayan VA. Helen A (2007). Protective activity of Bacopa monniera Linn. on

nicotine-induced toxicity in mice. Phytother Res; 21: 378–81. Vohora D, Pal SN, Pillai KK (2000). Protection from phenytoin-induced cognitive

deficit by Bacopa monniera, a reputed Indian nootropic plant. J Ethnopharmacol; 71:383–90.

241

Wakdikar S (2004). Global health care challenge: Indian experiences and new

prescriptions. Electr J Biotechnol; 7: 214–20. Waksman JC, Heard K, Joliff H, Daly FF, Bogdan GM, Dart RC (2000). Serotonin

syndrome associated with the use of St. John’s wort and paroxetine. J Toxicol Clin Toxicol; 38: 521.

Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD (2001). The effects

of St John’s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther; 70: 317–26.

Wanwimolruk S, Wong K, Wanwimolruk P (2009). Variable inhibitory effect of

different brands of commercial herbal supplements on human cytochrome P-450 3A4. Drug Metab Drug Interact; 24: 17–35.

Weissback, H, Waalkes TP, Udenfriend S (1958). A simplified method for measuring

serotonin in tissues: simultaneous assay of both serotonin and histamine. J Biol Chem; 230: 865–71.

Wilkinson GR (1997). The effects of diet, aging and disease-states on presystemic

elimination and oral drug bioavailability in humans. Adv Drug Deliv Rev; 2: 129–59. Will CC, Aird F, Redei EE (2003). Selectively bred Wistar-Kyoto rats: an animal

model of depression and hyper-responsiveness to antidepressants. Mol Psychiatr; 8: 925–32.

Williamson EM (2003). Drug interactions between herbal and prescription medicines.

Drug Saf; 26: 1075–92. Willner P (1991). Animal models as simulations of depression. Trends Pharmacol Sci;

12: 131–6. Willner P (1984). The validity of animal models of depression. Psychopharmacol; 83:

1–16. Willner P (1997). Validity, reliability and utility of the chronic mild stress model of

depression: A 10-year review and evaluation. Psychopharmacol; 134: 319–29. Willner P, Sampson D, Phillips G, Fichera R, Foxlow P, Muscat R (1989). Effects of

isolated housing and chronic antidepressant treatment on cooperative social behaviour in rats. Behav Pharmacol; 1: 85–90.

Will-Shahab L, Bauer S, Kunter U, Roots I, Brattström A (2009). St. John's wort

extract does not alter the pharmacokinetics of a low-dose oral contraceptive. Erratum in: Eur J Clin Pharmacol; 65: 541.

Winker MA, Flanagin A, Chi-Lum B, White J, Andrews K, Kennett RL, et al (2000).

Guidelines for medical and health information sites on the internet: principles governing AMA web sites. JAMA; 283:1600–6.

Woodcock J (2007). The prospects for ‘‘personalized medicine’’ in drug development

and drug therapy. J Clin Pharmacy Ther; 81: 164–9. Wootton J (2004). Directory of databases. The Vienna international academy for

integrated medicine. The Rosenthal center for complementary and alternative medicine.Available from: http://cpmcnet. columbia.edu/dept/rosenthal/Databases.html (Consulted, May 1, 2006).

242

WHO (2002). World health organization/ Geneva. Quality control methods for

medicinal plant materials. p. 41–3. Wrynn AS, Mac Sweeney CP, Franconi F, Lemaire L, Pouliquen D, Herlidou S, et al

(2000). An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression. Brain Res; 879: 193–9.

Xia X, Cheng G, Pan Y, Xia ZH, Kong LD (2005). Behavioral, neurochemical and

neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test. J Ethnopharmacol (Article in Press).

Xie HG, Kim RB (2005). St. John’s wort-associated drug interactions: short-term

inhibition and long-term induction? Clin Pharmacol Ther; 78:19–24. Xu Y, Cao Z, Khan I, Luo Y (2008). Gotu Kola (Centella asiatica) extract enhances

phosphorylation of cyclic AMP response element binding protein in neuroblastoma cells expressing amyloid beta peptide. J Alzheimers Dis; 13: 341–9.

Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang Y, Li X (2005a). The effects of

curcumin on depressive-like behaviors in mice. Eur J Pharmacol; 518: 40–6. Yadid G (1998). The need for cautiously extrapolating results obtained with normal

animals (healthy individuals) to depressed ones. J Neurochem; 70: 2642–42. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang, YH, et al (2005b). Antidepressant

effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav; 82: 200–6.

Yu ZF, Kong LD, Chen Y (2002). Antidepressant activity of aqueous extracts of

Curcuma longa in mice. J Ethnopharmacol; 83: 161–5. Yue QY, Jansson K (2001). Herbal drug and anticoagulant effect with and without

warfarin: possibly related to vitamin E component (Letter). J Am Geriatr Soc; 49: 838.

Zheng CJ, Qin LP (2007). Chemical components of Centella asiatica and their

bioactives. J Chin Integr Med / Zhong Xi Yi Jie He Xue Bao; 5: 348–51. Zhou S, Lai X (2008). An update on clinical drug interactions with the herbal

antidepressant St. John's wort. Curr Drug Metab; 16: 394–409. Zhou S (2007). Herbal medicine and drug interactions. Innovation: The magazine of

research & Technology. World Scientific Publishing Co. and National University of Singapore. Available from: http://www.innovationmagazine.com/innovation/volum es/v6n2/coverstory3.shtml (Consulted, June 10, 2007).

Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW (2003). Interactions of herbs

with cytochrome P450. Drug Metab Rev; 35: 35–98. Zhou S, Lim LY, Chowbay B (2004). Herbal modulation of P-glycoprotein. Drug

Metab Rev; 36: 57–104. Zuber R, Modriansky M, Dvorak Z, Rohovsky P, Ulrichova J, Simanek V, et al (2002).

Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities. Phytother Res; 16: 632–8.

243

10. List of publications and presentations:

Publications

1. Gohil KJ, Patel JA. A review on Bacopa monniera: current research and future

prospects. Int J Green Pharmacy. Article accepted, date: 5-6-2009. 2. Patel JA, Gohil KJ. Warfarin herb interactions: a review and study based on

assessment of clinical case reports in literature. Bol latinoam caribe plant Med Aromaticas 2008; 7 (3): 1-16.

3. Gohil KJ, Patel JA. Herb-drug interactions: a review and study based on

assessments of clinical case reports in literature. Ind J Pharmacol 2007; 39 (3): 129-139.

Papers presented at various conference proceedings

1. Gohil KJ, Patel JA. Potential drug interactions with Curcuma longa: neuropsycho pharmacological studies on mice behavioural models.

International conference on ‘Translational Pharmacology’ and 41st annual Conference of Indian Pharmacology Society (IPS). AIIMS, New Delhi. December 18-20, 2008. Oral presentation in U. K. Sheth prize session (642/UP 04).

2. Gohil KJ, Patel JA. Potential drug interactions with Bacopa monniera: a Lab Study. IXth World Conference of Clinical Pharmacology and Therapeutics. CPT 2008. Quebec, Canada. July 27- August 1, 2008. Received a grant of 1000$ (CAD) from NRC & IUPHAR, Canada. (National Research Council, Canada).

3. Gohil KJ, Patel JA. Potential drug interactions with Centella asiatica: neuropsychopharmacological studies on mice behavioural models. 26th Annual Conference of IPS, Gujarat Chapter, 2008. ROEFL, Vapi, Gujarat, March 15-16, 2008. Oral presentation in prize session.

4. Satani, BA, Gohil, KJ, Patel JA. A study on spontaneous motor activity and motor coordination in rats after 1-week, chronic, oral administration of Bacopa monniera and fluoxetine.

59th IPC, 2007, Varansi. Poster- D-125.

5. Gohil KJ, Patel JA. Herb-drug interactions: a focus on warfarin. Association of Physiologists and Pharmacologists (APPICON), 2006.

SMIMER, Surat, Gujarat, India Oral- OP078 (in IJPS, 52 (5) 2006). 6. Gohil KJ, Patel JA, Trivedi PD. A study on herbal drug interaction information-

Pharmacovigilance is need of the hour. Fifth annual conference of society of Pharmacovigilance 2005. LMCP, Ahmedabad, 11-13, November, 2005. Oral/Prize session (PZ1).